2025 Annual Meeting | S7 - Autoimmune Encephalitis
Program Materials Program Evaluations
| Mayra Montalvo Perero, MD | Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. |
| Grace Gombolay, MD | Dr. Gombolay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH. |
| Mitsuyuki Matsumoto, PhD | Dr. Matsumoto has received personal compensation for serving as an employee of Arialys Therapeutics, Inc.. Dr. Matsumoto has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Arialys Therapeutics, Inc.. Dr. Matsumoto has stock in Arialys Therapeutics, Inc.. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care. |
| Amir Razai | Amir Razai has received personal compensation for serving as an employee of Arialys . |
| Scott Snipas | Scott Snipas has received personal compensation for serving as an employee of Arialys Therapeutics . |
| Shanni Yamaki | Shanni Yamaki has received personal compensation for serving as an employee of Arialys Therapeutics Inc. . |
| Roghiye Kazimi | Roghiye Kazimi has nothing to disclose. |
| Vallari Eastman | Vallari Eastman has nothing to disclose. |
| Mari Maurer | Ms. Maurer has received personal compensation for serving as an employee of Arialys Therapeuticss, Inc.. Ms. Maurer has received personal compensation for serving as an employee of ESCAPE Bio. Ms. Maurer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ReCode Therapeutics. Ms. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momentum Pharma. Ms. Maurer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ESCAPE Bio. Ms. Maurer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys Therapeutics. |
| Mathew Mitchell | Mr. Mitchell has received personal compensation for serving as an employee of Arialys Therapeutics. |
| Martin Jefson, PhD | Dr. Jefson has received personal compensation for serving as an employee of Arialys Therapeutics. Dr. Jefson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Arialys Therapeutics. |
| Jay Lichter, PhD | Dr. Lichter has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Janux. |
| Peter Flynn, PhD | Dr. Flynn has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Artiva. Dr. Flynn has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Arialys. |
| Xiaoyang Li, MD | Dr. Li has nothing to disclose. |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Alfonso S. Lopez, MD | Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . |
| Pranjal Gupta, MD | Dr. Gupta has nothing to disclose. |
| Naveen K. Paramasivan, MD | Dr. Paramasivan has nothing to disclose. |
| Eoin P. Flanagan, MBBCh, FAAN | The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Jeffrey W. Britton, MD, FAAN | Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society. |
| Anastasia Zekeridou, MD, PhD, FAAN | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Gregory S. Day, MD, MSc, FAAN | Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Reza Seyedsadjadi, MD | Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DYSIMMUNE DISEASES FOUNDATION. The institution of Dr. Seyedsadjadi has received research support from AAN. |
| Cristina Valencia Sanchez, MD | Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities. |
| Ezgi Saylam, MD | Dr. Saylam has nothing to disclose. |
| Claudia Papi, MD | Dr. Papi has nothing to disclose. |
| Laura Marmolejo Alcaide | Miss Marmolejo Alcaide has nothing to disclose. |
| Alexandra Sankovic, MD | Dr. Sankovic has nothing to disclose. |
| Jerome Honnorat, MD, PhD | The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology. |
| Takahiro Iizuka, MD | The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd. |
| Romana Hoeftberger | Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun and UCB Biopharma. |
| Raphael Reinecke, MD | Dr. Reinecke has nothing to disclose. |
| Maarten J. Titulaer, MD, PhD | The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received publishing royalties from a publication relating to health care. |
| Jeroen Kerstens, MD | Jeroen Kerstens has received research support from European Joint Programme on Rare Diseases. Jeroen Kerstens has received research support from Erasmus Trust Fund. |
| Mateus M. Simabukuro, MD | Dr. Simabukuro has nothing to disclose. |
| Marie Benaiteau, MD | Dr. Benaiteau has nothing to disclose. |
| Bastien Joubert | Bastien Joubert has nothing to disclose. |
| Matteo Gastaldi, MD, PhD | Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB, AMGEN, ROCHE, ALEXION. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health. |
| Livia A. Dutra, MD | The institution of Dr. Dutra has received research support from Hospital Israelita Albert Einstein. |
| Frank Leypoldt, MD | Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argen. The institution of Frank Leypoldt, MD has received research support from German Ministry of Research BMBF. |
| Mareike Jansen, Medical Student | Ms. Jansen has nothing to disclose. |
| Izumi Kawachi, MD, PhD | Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Mochida Pharmaceutical CO., LTD.. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Euroimmune. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Argenx. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Dr. Kawachi has received research support from JSPS KAKENHI. Dr. Kawachi has received research support from MHLW Research Program on Rare and Intractable Diseases. Dr. Kawachi has received research support from Japan Kampo Medicine 好色先生 Foundation. |
| Eugenia Martinez-Hernandez, MD | Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Sanofi. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a speaker honoraria with Terumo. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Janssen. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring. |
| Thais Armangue, MD | Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP. |
| Francesc R. Graus, MD | Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care. |
| Josep O. Dalmau, MD, PhD, FAAN | Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
| Setty Magana, MD, PhD | Dr. Magana has nothing to disclose. |
| Marianna Spatola, MD, PhD | The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. |
| Chiara Milano, MD | Dr. Milano has nothing to disclose. |
| Albert Aboseif, DO | Dr. Aboseif has a non-compensated relationship as a AAN Autoimmune Neurology Section -- 好色先生 Workgroup with AAN that is relevant to AAN interests or activities. |
| Georgios Mangioris, MD | Dr. Mangioris has nothing to disclose. |
| Binxia Yang | Binxia Yang has nothing to disclose. |
| Yahel Segal, MD | Dr. Segal has nothing to disclose. |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma.. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Michel Toledano, MD | Dr. Toledano has nothing to disclose. |
| Ivana Vodopivec, MD | Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche. |
| Tapasya Surti, DO | Dr. Surti has nothing to disclose. |
| Omolara D. Kolawole, MD | Dr. Kolawole has nothing to disclose. |
| Rajesh K. Gupta, MBBS | Dr. Gupta has nothing to disclose. |
| Sienna Wu | Ms. Wu has nothing to disclose. |
| Ralph Habis, MD | Dr. Habis has nothing to disclose. |
| Ashley Heck, MD | Dr. Heck has nothing to disclose. |
| Paris Bean, MD | Dr. Bean has nothing to disclose. |
| Rodrigo Hasbun | Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux. |
| Arun Venkatesan, MD, PhD | Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from MSRCF. The institution of Dr. Venkatesan has received research support from U.S. DOD. |
| John Probasco, MD, FAAN | Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch Neurology. The institution of Dr. Probasco has received research support from Roche/Genentech. |
| Esther Aguilar, Bachelor of science | Mrs. Aguilar has nothing to disclose. |
| Maja Pucic Bakovic, PhD | Dr. Pucic Bakovic has nothing to disclose. |
| Ivana Duvnjak Orešković, MSc | Ms. Duvnjak Oreškovic has nothing to disclose. |
| JERKO ŠTAMBUK, PhD | Mr. ŠTAMBUK has nothing to disclose. |
| Estibaliz Maudes, PhD | The institution of Dr. Maudes has received research support from Basque Government PhD fellowship. The institution of Dr. Maudes has received research support from ECTRIMS. |
| Gemma Olivé, MD | Dr. Olivé has nothing to disclose. |
| Jonathan Lee | Jonathan Lee has nothing to disclose. |
| Jeffrey Lambe, MD | Dr. Lambe has nothing to disclose. |
| Scott Johnson | No disclosure on file |
| Akua Abrah | Akua Abrah has nothing to disclose. |
| Tatchaporn Ongphichetmetha | Miss Ongphichetmetha has nothing to disclose. |
| Jennifer Bullen | Ms. Bullen has nothing to disclose. |
| Amy Kunchok, MBBS | Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journal . Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal . |
| Jesus Planaguma | The institution of Dr. Planaguma has received research support from Spanish national Institute of Heath. |
| Raquel Bello-Morales, PhD | Dr. Bello-Morales has nothing to disclose. |
| Aiqing Li, PhD | Mrs. Li has nothing to disclose. |
| Linjun Cai, PhD | Linjun Cai has nothing to disclose. |
| Zhen Hong | No disclosure on file |
| Marija Radosevic, PhD | Dr. Radosevic has nothing to disclose. |
| Ana Beatriz Serafim, MSc | Miss Serafim has received research support from Fundação para as ciências e tecnologia. |
| Carlos Sindreu | Dr. Sindreu has nothing to disclose. |
| Jon Landa Medrano, PhD | Dr. Landa Medrano has nothing to disclose. |
| Anna García-Serra, PhD | Dr. García-Serra has nothing to disclose. |
| Francesco Mannara, PhD | Dr. Mannara has received personal compensation for serving as an employee of Harvard Bioscience. |
| Marina Cunquero, PhD | Dr. Cunquero has nothing to disclose. |
| Anna Smit, PhD | Mrs. Smit has nothing to disclose. |
| Paula P. Peixoto | Ms. Peixoto has nothing to disclose. |
| Mar Guasp, MD | Dr. Guasp has nothing to disclose. |
| Raquel Ruiz García, PhD | Dr. Ruiz García has nothing to disclose. |
| Pablo Loza-Alvarez, PhD | Dr. Loza-Alvarez has nothing to disclose. |
| Carlos Matute, PhD | Prof. Matute has nothing to disclose. |
| Lidia Sabater, PhD | The institution of Dr. Sabater has received research support from Instituto de Salud Carlos III. |
| Sarah Gray | Sarah Gray has received personal compensation for serving as an employee of Sage Therapeutics. Sarah Gray has stock in Sage Therapeutics. |
| Yue Liu | Ms. Liu has nothing to disclose. |